From the University of Central Florida.
Pediatr Emerg Care. 2022 Sep 1;38(9):e1564-e1568. doi: 10.1097/PEC.0000000000002608. Epub 2021 Dec 23.
This study aimed to describe the resource utilization of nurse practitioners (NPs) in the pediatric emergency department (ED) and compare among physicians.
A retrospective cross-sectional study of secondary data analysis in a level 1 academic pediatric trauma center was conducted. Patients were aged 1 to 24 months, evaluated in the ED between January 1, 2014, and November 30, 2018, with a diagnosis of bronchiolitis or wheezing. Data included age group, length of stay, disposition, diagnostic tests (chest radiography [CXR], viral testing, respiratory syncytial virus test), treatment (bronchodilator, corticosteroid, antibiotic), and medical provider (physician, NP, combination of both). Resources were evaluated before (early era) and after (late era) the implementation of an institutional clinical practice guideline.Comparisons between groups were done through χ2, Fisher exact, or Kruskal-Wallis test, as appropriate.
A total of 5311 cases were treated by a physician (65.3%), an NP (30.3%), or a combination of both (4.3%). The was a difference in the use of CXR, respiratory syncytial virus testing, bronchodilators, and corticosteroids among providers (P = 0.001). In the late era, NPs were less likely to order a bronchodilator (odds ratio [OR], 0.390 [95% confidence interval, 0.318-0.478; P < 0.001]), whereas physicians were less likely to order a CXR (OR, 0.772 [0.667-0.894, P = 0.001]), bronchodilator (OR, 0.518 [0.449-0.596, P < 0.001]), or a corticosteroid (OR, 0.630 [0.531-0.749, P < 0.001]).
Nurse practitioners made fewer diagnostic and therapeutic orders. A clinical practice guideline on the diagnosis and management of children with bronchiolitis successfully decreased the use of nonrecommended tests and therapies among NP and physicians.
本研究旨在描述儿科急诊部(ED)中护士从业者(NP)的资源利用情况,并对其与医生进行比较。
对一家一级学术儿科创伤中心的二次数据进行回顾性横断面研究。患者年龄为 1 至 24 个月,2014 年 1 月 1 日至 2018 年 11 月 30 日在 ED 接受评估,诊断为细支气管炎或喘息。数据包括年龄组、住院时间、处置、诊断性检查(胸部 X 光检查[CXR]、病毒检测、呼吸道合胞病毒检测)、治疗(支气管扩张剂、皮质类固醇、抗生素)和医疗服务提供者(医生、NP、两者的组合)。资源在实施机构临床实践指南前后(早期和晚期)进行评估。通过 χ2、Fisher 精确检验或 Kruskal-Wallis 检验进行组间比较,具体取决于数据类型。
共有 5311 例患者由医生(65.3%)、NP(30.3%)或两者的组合(4.3%)治疗。提供者之间在 CXR、呼吸道合胞病毒检测、支气管扩张剂和皮质类固醇的使用上存在差异(P = 0.001)。在晚期,NP 开具支气管扩张剂的可能性较小(比值比[OR],0.390[95%置信区间,0.318-0.478;P<0.001]),而医生开具 CXR 的可能性较小(OR,0.772[0.667-0.894,P = 0.001])、支气管扩张剂(OR,0.518[0.449-0.596,P<0.001])或皮质类固醇(OR,0.630[0.531-0.749,P<0.001])的可能性较小。
NP 开具的诊断和治疗性医嘱较少。一项关于儿童细支气管炎诊断和管理的临床实践指南成功减少了 NP 和医生之间非推荐检查和治疗的使用。